There are little data on longterm outcomes, health-related quality of life (HRQoL), and issues related to living donor right hepatectomy specifically. We studied longterm HRQoL in 127 living liver donors. A donor-specific survey (DSS) was used to evaluate the living liver donor morbidity, and the 36-item short-form health survey (short-form 36 health survey, version 1 [SF-36]) was used to assess generic outcomes. The DSS was completed by 107 (84.3%) donors and the SF-36 by 62 (49%) donors. Median follow-up was 6.9 years. Of the 107 donors, 12 (11.2%) donors reported their health as better, whereas 84 (78.5%) reported their health the same as before donation. Ninety-seven (90.7%) are currently employed. The most common postdonation symptom was incisional discomfort (34%). Twenty-four donors (22.4%) self-reported depression symptoms after donation. Ninety-eight (91.6%) rated their satisfaction with the donation process 8 (scale of 1-10). Three factors-increased vitality (correlation, 0.44), decreased pain (correlation, 0.34), and a recipient who was living (correlation, 0.44)-were independently related to satisfaction with the donor experience. Vitality showed the strongest association with satisfaction with the donor experience. Mental and physical component summary scale scores for donors were statistically higher compared to the US population norm (P < 0.001). Donors reported a high satisfaction rate with the donation process, and almost all donors (n 5 104, 97.2%) would donate again independent of experiencing complications. Our study suggests that over a longterm period, liver donors continue to have above average HRQoL compared to the general population. Liver Transpl 22:53-62, 2016. V C 2015 AASLD.
Liver transplantation remains the only treatment for end-stage liver disease. Sadly, there is a shortage of deceased donors needed to meet the demands. In 2012, there were over 16,000 patients on the waiting list for a liver, 6878 underwent transplantation and 6999 died while waiting. 1 Of those receiving a transplant, 96% received deceased donor transplants and only 4% were living donor liver transplantations (LDLTs). 1 Increasing LDLT represents a possible alternative to help alleviate the organ shortage. However, the safety of the donor must be of paramount consideration, and potential donors should have a broad, clear understanding of the potential short-term and longterm effects of LDLT on the donor. The donor operation has well-documented early risks: (1) mortality rates of 0.4%-0.5% for right lobe and 0.09% for left lobe donation 2, 3 and (2) surgical morbidity 38%-47%. [4] [5] [6] [7] LDLT is one of the most selfless and humane acts a person can perform. It is the responsibility of the transplant community to educate the donors on all aspects of the donation process, including early quality of life (QoL) as well as QoL years after donation.
Continued research in this area cannot be over emphasized. For example, living donor kidney transplants have been performed since the 1950s, and all studies until now have shown the short-and longterm safety of donation; however, Muzaale et al. 8 recently published data suggesting that kidney donors have an increased risk of end-stage renal disease when compared to healthy matched nondonors. This only strengthens the argument that continued research in organ donation is of vital importance.
There are little data on longterm outcomes, healthrelated quality of life (HRQoL), and donor-specific concerns. 9 Ladner et al. 5 recently published a longterm QoL study using the short-form 36 health survey, version 1 (SF-36) but did not include donor-specific aspects. In addition, the length of follow-up in most previous studies has been fairly short. Parikh et al. 10 published a systematic review in 2010 of 19 QoL studies, and median follow-up range was 9-13.7 months. In 2010, Adcock et al. 7 from the University of Toronto published longterm outcomes of 202 donors with mean follow-up time of 33.9 months and concluded that longterm medical and psychiatric complications were relatively rare; but again, they focused on complications and did not assess any HRQoL metrics. Additionally, this study was a retrospective chart review, and for some donors, they relied on the visits with general practitioners who may not inquire about liver donorspecific issues or psychiatric issues. 7 In 2012, Takada et al. 11 published a historical cohort study describing their longterm results using the SF-36 (mean followup, 6.8 years). Although the mean follow-up time period is excellent and they did take into account multiple comorbidities (such as hypertension; diabetes; cerebrovascular disease; myocardial infarction; hyperlipidemia; angina pectoris; heart failure; anemia; eye, pulmonary, gastrointestinal, renal, or genitourinary disease; arthritis or rheumatism; dermatological, neurological, psychiatric, endocrine, gynecological, or pancreatic disease; and cancer), it was a HRQoL study without donor-specific issues being assessed.
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One aspect missing from other longterm studies was a lack of donor-specific evaluation addressing symptoms and issues related to the right donor hepatectomy specifically experienced by living donors after donation both physically and psychologically. [10] [11] [12] Parikh et al. 10 review of the liver donor literature reported between 4% and 26% of donors experience some level of psychological morbidity, and Trotter et al. 13 confirmed that some donors experience severe psychiatric complications. Even more disturbing, Castedal et al. 9 found that only 53% of donors reported being well informed about the potential longterm complications and that 47% stated they had little to no information on the longterm effects of donation. This emphasizes the importance of more longterm studies in living liver donors to allow for a more complete informed consent. In this study, we explore the health status of living liver donors and prevalent longterm morbidity as a result of liver donation focusing on psychosocial outcomes and satisfaction with the donor experience. This was our attempt to combine a QOL study with specific concerns from the right lobe hepatectomy.
PATIENTS AND METHODS
This study was approved by the institutional review board at the University of Minnesota (No. 0301M39762). All living liver donations performed at the University of Minnesota between 1997 and 2011 with a minimum of 2 years or more postdonation follow-up were included in the study. Donor demographic data and postoperative complications were gathered from a clinical transplant database that is prospectively maintained for the program. Donors follow up with the institution immediately after the operation, at 1 year, and at 2 years and are called yearly thereafter. The database of complications includes complications up to 1 year after donation. Early postoperative complications were defined as complications occurring within 1 year after donation and were categorized according to the Clavien classification scheme. The donor survey packet consisted of 2 surveys: (1) a donor-specific survey (DSS) designed to address donor concerns about LDLT ( Fig. 1 ) and (2) the RAND version of the SF-36 to assess HRQoL. [14] [15] [16] Because there was no standardized liver donor survey available for use, we developed a DSS based on a literature review of living liver donation. [2] [3] [4] [5] [6] [7] [9] [10] [11] [12] [13] [17] [18] [19] [20] [21] [22] [23] The annotated version of the survey shown in Fig. 1 broadens the scope of outcomes assessment to include specific symptoms and complications associated with liver donation in earlier studies. Before use, the DSS was reviewed for face validity, and revisions were made for donor self-administration by mail and telephone interview. Construct validity was evaluated using a multitrait-multimethod matrix that was composed of DSS items and scale scores derived from the SF-36 generic health survey. This analysis was restricted to ongoing symptoms with a prevalence of at least 10%.
Generic health status was measured using SF-36. [14] [15] [16] This measure has been shown to have acceptable reliability and to be valid as a measure of HRQoL assessment in a number of patient groups (diseased and healthy) across disparate cultures. Responses from the SF-36 can be used to create 8 health scores: physical functioning, role-physical, bodily pain, general health, social functioning, vitality, role-emotional, and mental health. The scale scores are used to create the component summaries, physical component summary (PCS) and mental component summary (MCS) scores. SF-36 scale scores were normalized to the US population permitting comparison of donor responses to the US population norm. Before administration of the surveys, donors were called and consent was obtained for study participation. A telephone interview was used for completing the DSS; the SF-36 was dispersed using a mailed selfadministered questionnaire. For the telephone interviews, professionally trained student interviewers were employed. All interviews used a standard script.
A $10 monetary incentive was provided for completion of the DSS, and a $15 incentive was provided for the SF-36 survey. We specifically paid more for completion of the SF-36 survey because more time is needed to complete the survey compared to the DSS.
Statistical Analyses
Categorical variables were summarized as counts and percentages; continuous variables were summarized as a means and standard error of the mean. A multitrait-multimethod matrix was used to summarize the correlations between outcome variables. The correlations between SF-36 scale scores and morbidities due to donation were used to evaluate construct validity. Reliabilities were summarized along the matrix diagonals. Reliability for the multi-item SF-36 scales expressed a Cronbach's alpha; reliability for singleitems were estimated as the lower-bound for reliability, ie, the correlation between the item and the most similar score from the SF-36. For example, it is hypothesized that self-reported depression would be most strongly related to the MCS scores derived from the SF-36.
Multivariate logistic regression was used to evaluate independent risk factors for depression. Evidence for an association between risk factors and the prevalence of depression was evaluated in terms of an adjusted odds ratio. Multivariate regression model fit was evaluated for discrimination using the area under the curve. Calibration of the multivariate logistic model was tested using the Hosmer-Lemeshow chisquare. Satisfaction with the donation experience was evaluated using least-squares linear regression. The results from this driver analysis were expressed as an analysis of variance with independent drivers summarized as unstandardized and standardized coefficients. All analyses were performed using SAS/STAT, version 9.3 (SAS Institute, Chicago, IL).
RESULTS
The study cohort consisted of 127 living liver donors between 2 years and 16 years after donation. Of these, 108 (85.0%) were right lobe adult-to-adult donations, 18 (14.2%) were left lateral segment donors to pediatric recipients, and one was a domino liver donor and excluded from the study. Five donors were lost to follow-up (2 were incarcerated, 1 out of the country, and 2 unknown). Of the 127 donors, 107 donors responded to the DSS (84.3%) and 62 responded (48.8%) to the SF-36. Median follow-up was 6.9 years.
Demographics
Characteristics of responders and nonresponders to the DSS can be seen in Table 1 . There were statistical differences between responders and nonresponders by age (P 5 0.03) and sex (P 5 0.02). Our responders tended to be older and female. Recipient deaths were more common in the nonresponders (P < 0.001). Eighty-six (80.4%) of the donors' recipients were still alive at follow-up, and 21 (19.6%) were deceased (of those that responded). Of the recipients alive, 69 (80.2%) were reported to be in good health, and 17 (19.8%) were in poor health or status unknown.
Reliability and Construct Validity for the DSS and SF-36
The intercorrelation of the SF-36 scale score and DSS items are shown in Table 2 . Arranged in the form of a multitrait-multimethod matrix, the estimates of reliability are provided along the diagonal. The SF-36 scale scores were moderately intercorrelated with one another, whereas the single-item symptoms are weakly associated. The Cronbach's coefficient alpha exceed 0.8 for the SF-36 scale scores and the component summary scale scores. The lower-bound reliability for the symptom questions were indirectly estimated using a corresponding component summary from the SF-36. These results suggest that among the single-item questions, self-reported depression, and change in eating habits likely provide the most stable measures. These relatively correlations are not too surprising given the weak associations found between generic and specific patient-reported measures that were reported.
Donor-Specific Survey
The results of the DSS are shown in Table 3 . The answers were stratified between those donors reporting depression and those not reporting depression.
In relation to current health, 11 (10.3%) donors reported their health as better, 84 (78.5%) reported their health as the same, and 12 (11.2%) reported their health as worse than before donation (Table 3) . Self-esteem compared to before donation was reported better by 33 (30.8%) donors, same by 70 (65.4%), and worse by 4 (3.7%). Of the 107 responders, 97 donors (90.7%) reported being currently employed, and 10 (9.3%) reported being unemployed after donation. None of the donors felt that donation was the cause of their unemployment. Sixty-nine (64.5%) donors reported no new health problems since donation, and 38 (35.5%) reported new health problems since donation (Table 4) . One hundred (93.5%) donors reported no worsening of their predonation medical conditions, and 7 (6.5%) reported some worsening. The medical conditions reported to worsen were back/neck pain, insomnia, intolerance to fatty meals, weight gain, worsening of "delicate digestive system," worsening of cognitive abilities (described as brain fog), and arthritis. Twenty-four donors (22.4%) reported current depressive symptoms or clinically diagnosed depression, and 83 (77.6%) reported no issues with depression. Of the 24 reporting depression, 8 (33%) were male and 16 (66%) were female. Eleven (45.8%) donors reporting depression had been diagnosed with depression before donation and 13 (54.2%) had no history of depression before donation.
The most commonly reported postdonation symptoms are shown in Fig. 2 . Incisional discomfort was the most frequently reported. We further evaluated the number of symptoms reported by our donors and 37 (34.6%) reported no current symptoms, 48 (44.9%) reported 1 to 2 symptoms, 16 (15.0%) reported 3 to 4 symptoms, and 6 (5.6%) reported 5 or more symptoms.
We looked at the early postoperative complications incurred by donors in our series. Fifty-four of the 127 donors had complications (complication rate of 42.5%). Subdivided into left and right lobe donation, NOTE: All data are given in n (%). Table 5 . Donors liked that we checked on them yearly with surveys and a phone call. They stressed the importance of showing compassion for the donor from the entire team. Several donors expressed concerns and frustrations with the amount of time it took for the workup and scheduling of the donation.
SF-36
Sixty-two (48.8%) of the 127 donors completed the SF-36. Figure 3 shows the SF-36 scale score means and 95% confidence intervals (CIs) compared to a representative sample drawn from the United States. Among those responding, HRQoL for living liver donors as measured by the SF-36 is significantly greater than standard normal US population. This is found for each of the 8 SF-36 subscales and the 2 component summary scale scores, and PCS and MCS scores. This health status pattern was found for each time interval following living liver donation. The MCS and PCS scores for intervals after donation of 2 to 5 years, 5 years to 10 years, and >10 years are shown in Fig.  4 . For each interval of time, both the MCS and PCS scores were statistically higher (P < 0.001) than the US population norm.
Satisfaction With the Donor Process
Donors rated their satisfaction with the donation process on a scale of 1 to 10. A Fisher's exact test was used to determine the break point for a statistically low satisfaction score. Results from our analysis suggest a satisfaction rating of less than 8 meets this criteria. Ninety-eight (91.6%) donors scored their experience between 8 and 10. Nine donors (8.4%) reported a satisfaction score between 1 and 7. Of these 9 donors reporting low satisfaction scores, 6 had early postoperative complications. The status of the recipient was evaluated in the 9 donors that gave lower satisfaction scores, and 7 of the 9 donors' recipients were still alive. There was no correlation between lower satisfaction scores and death of the recipient. A least squares linear regression for satisfaction with the donor experience was performed. Three factors-increased vitality (correlation, 0.44), decreased pain (correlation, 0.34), and a recipient who was living (correlation, 0.44)-were independently related to satisfaction with the donor experience. Vitality showed the strongest association with satisfaction with the donor experience. These 3 factors accounted for 30% of the variability between satisfaction scores (r 2 , 0.30; adjusted r 2 , 0.27). As an alternate measure of donor satisfaction, we asked our donors if they would be willing to donate again; 104 (97.2%) patients reported they would, 0 (0.0%) said they would not, and 3 (2.8%) were unsure if they would donate again.
DISCUSSION
The aim of our study was to describe the longterm effects of liver donation, including health problems and perception of the donation process. Our study is unique in that we combined a DSS addressing donor issues along with a standardized survey, the SF-36. The latter generic HRQoL measure enabled us to compare donors to the population norm. One aspect missing from other longterm studies was a lack of a DSS addressing symptoms and issues specifically experienced by living liver donors. [10] [11] [12] This was our attempt to combine a QOL study with specific concerns after a right hepatectomy.
The response to our DSS was excellent (84.3%), and median postdonation follow-up was 6.9 years (mean, 7.7 6 3.4 years; range, 2-15.7 years). To our knowledge, this is one of the longest follow-up studies published. It had been suggested in other studies that death of a recipient may make a donor less likely to participate in follow-up surveys. 10, 17, 18 Miyagi et al. 17 reported only 40% response rate for donors whose recipients had died, and Takada et al. 11 also reported attenuated responses from this group of donors. Similarly, we found that 40% of the nonresponders' recipients were deceased and that only 19.6% of the responders' recipients were deceased, which reached significance. One may postulate that responses may differ from donors whose recipient is deceased and may decrease the QOL scores, increase depression rates, and decrease satisfaction scores.
The reliability for the surveys was weakest for incisional discomfort. This may be due to the crosssectional design of our study and querying donors at differing points after donation. We may also see a difference due to the amount of education provided to the donor before donation. Some donors may have expected incisional discomfort because it was emphasized more during the predonation education than others.
Financial stress is extremely important to the donors; therefore, return to work after donation is an important aspect to investigate. Most of our donors had returned to work, with 90.7% reporting current employment. There were 10 unemployed donors; however, they did not feel as though the donation was the cause of their unemployment. In hindsight, it would have been advantageous to inquire if they had returned to the same type of work or if they changed careers as a result of the donation and to determine time to return to employment. Previous studies indicate a return to employment for 84% by 6 months and that a change in employment was not due to donation. 19 Our study reaffirms the previous data suggesting that donation does not affect employment.
The psychiatric stability of the donor before donation is rigorously assessed but after donation is not routinely evaluated. Parikh et al. 10 review of the liver donor literature reported between 4% and 26% of donors experience some level of psychological morbidity, and Trotter et al. 13 confirmed that some donors experience severe psychiatric complications. Others have suggested there are positive psychological benefits to living organ donation. 20 In our series, a surprise finding was 24 (22.4%) donors reported depression symptoms, either treated or untreated with medications. This was self-reported depression. This self-reported depression was rather an unexpected finding in our series. We clearly intend to further evaluate this finding in our future studies with criteria that meet clinically diagnosed depression according to the Diagnostic and Statistical Manual of Mental Disorders, edition 4 (DSM IV). Overall, our donors were satisfied with their donation experience with 91.6% rating their experience between an 8 and 10 on a 10-point numerical rating scale regardless of complications or death of the recipient. Satisfaction with the experience did not correlate with death of the recipient or complications as was observed in other follow-up studies. 4, 9, 11, [21] [22] [23] There were 3 factors that were found to be independent related to higher satisfaction scores. These were increased vitality as determined by the SF-36, decreased pain as determined by the SF-36, and whether the recipient is living as determined by the DSS. Vitality, which is a measure of energy level, was the strongest association with satisfaction. Our short-term complication rate was 42.5%, which is in line with current reported literature. 4, 7, 24 Although there is high early morbidity associated with LDLT, donors' longterm satisfaction was not affected by experiencing early complications. This may reflect the fact that the complications had resolved and had been forgotten about or the informed consent had prepared them for the complications to come. Furthermore, the primary purpose of helping their recipient may be important enough to keep the satisfaction scores higher despite complications.
The SF-36 response rate was much lower than our DSS, which may be due to the mode of administration. The SF-36 was mailed and self-administered. In addition, the length of the survey and its perceived lack of specificity to donation might have obviated donor motivation to complete the measure. The SF-36 response rate was 48.8%, which is similar to Takada et al. 11 (58%). The most common postoperative symptoms reported were incisional discomfort, intolerance to fatty meals, diarrhea, heartburn, change in eating habits, and flatulence. In relation to the gastrointestinal symptoms, it is possible these are related to the cholecystectomy portion of the donor operation. Postcholecystectomy syndrome is characterized by pain, nausea, vomiting, dyspepsia, and diarrhea and occurs in 5% to 20% of patients undergoing cholecystectomy. 25 It can occur months to years after the surgery. 25 Several mechanisms for this phenomenon have been proposed, some of which pertain to our operation. Scar tissue can form between the duodenum and pylorus or from the duodenum to the liver causing an acute angle of the common bile duct impairing emptying. 25 The patient may experience sphincter of Oddi dysfunction causing distention of the bile duct, which has been shown to cause nausea and vomiting in humans. 26 During the cholecystectomy portion and portal dissection, there is disruption of the parasympathetic and sympathetic pathways to the bile duct, which may impair appropriate emptying. 25 Diarrhea can be caused by bile acid malabsorption, a well-known postcholecystectomy phenomenon that can be treated with bile acid salts such as cholestyramine. 27 The cholecystectomy portion of the operation is usually minimized, and 1 of our patients commented that they were never told they would have their gallbladder removed. More attention to describing all aspects of the operation, including the complications and/or side effects of gallbladder removal should be a part of the consent process. Patients reported certain medical conditions worsening after donation that have not been previously described as complications of a partial hepatectomy. Some of these conditions included neck and back pain, insomnia, weight gain, and "brain fog." It is unclear if the donors reported these symptoms and were associating them with donation or if they were just reporting any medical issues that were worse since donation. The question was not phrased to ask in relation to donation. In the future, we plan to continue this query of our donors and will make changes to the survey to better reflect the information we are trying to extract.
Our study has limitations. Comparing the postdonation SF-36 results to the general population may not be indicative of maintenance of QOL because the donors likely have higher scores at baseline. 10 In addition, the comparison of donors to the general population may be flawed because it was not age matched, and donors tend to be younger than the general population. Future work will include a comparison of the same donors' before and after SF-36 to ascertain maintenance of QOL after donation as well as comparison to age-matched general population.
The term depression in our study was not defined as clinical diagnosis by a physician or by DSM IV criteria. The depression was self-reported and some donors may have depression symptoms without having a diagnosis of depression. Therefore, the depression rate in our donors after donation might be unreliable.
Evaluating our demographics, it is obvious that our donor population consisted of mostly Caucasian donors with only a few Hispanic donors. The lack of cultural variance in our donor population can also be cited as a weakness of our study.
In summary, our study suggests that over a longterm period, liver donors continue to have above average HRQoL compared to the general population. Donors report a high satisfaction rate with the donation process, and almost all donors would donate again independent of experiencing complications. It is important to note the positive aspects of donation to the donor validated by this study, which include satisfaction with donation and a reported higher selfesteem. Although we cannot definitely determine the risk for postdonation depression from this crosssectional study, we feel that further studies are needed. We recommend more aggressive education about the longterm aspects of donation.
